Kantarjian H, Short NJ, Jain N, Sasaki K, et al. Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. Am J Hematol 2023 Jan 4. doi: 10.1002/ajh.26816.
PMID: 36600670